Enzychem Lifesciences Minority Shareholder Proxy Amendment Corrects Typo, No Financial Impact

Shareholder Nam Yun-hee corrected a typo in the proxy form of the proxy solicitation document initially filed on July 6, 2026, and added a PDF file.
The correction is limited to a clerical fix in the proxy form and does not affect the existing agenda or voting direction.
[AI Summary]This amendment is a mere clerical correction of the proxy form with zero financial impact on shareholder value. No financial figures were altered, maintaining a neutral stance.